.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Citi
AstraZeneca
Chubb
McKesson
Novartis
Johnson and Johnson
Julphar
Medtronic
Cipla

Generated: December 16, 2017

DrugPatentWatch Database Preview

Olodaterol hydrochloride; tiotropium bromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for olodaterol hydrochloride; tiotropium bromide and what is the scope of olodaterol hydrochloride; tiotropium bromide freedom to operate?

Olodaterol hydrochloride; tiotropium bromide
is the generic ingredient in one branded drug marketed by Boehringer Ingelheim and is included in one NDA. There are twenty-five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Olodaterol hydrochloride; tiotropium bromide has six hundred and four patent family members in fifty-two countries and eighteen supplementary protection certificates in twelve countries.

One supplier is listed for this compound.

Summary for olodaterol hydrochloride; tiotropium bromide

Pharmacology for olodaterol hydrochloride; tiotropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeYY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeYY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: olodaterol hydrochloride; tiotropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: olodaterol hydrochloride; tiotropium bromide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,610,163 Esters of thienyl carboxylic acids and amino alcohols and their quaternization products► Subscribe
6,402,055 Device for producing high pressure in a fluid in miniature► Subscribe
7,645,383Microstructured filter► Subscribe
6,503,440 Process for making a container with a pressure equalization opening and containers produced accordingly► Subscribe
7,451,884Container provided with a pressure equalization opening► Subscribe
6,918,547 Device for producing high pressure in a fluid in miniature► Subscribe
6,497,373 Device for producing high pressure in a fluid in miniature► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: olodaterol hydrochloride; tiotropium bromide

Country Document Number Estimated Expiration
Slovenia1539368► Subscribe
CroatiaP940723► Subscribe
Canada2562859► Subscribe
Australia716773► Subscribe
Colombia5700802► Subscribe
Australia2004311644► Subscribe
Czech Republic296984► Subscribe
Japan4411209► Subscribe
Australia2005243469► Subscribe
Poland183810► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB02/036United Kingdom► SubscribePRODUCT NAME: SCOPINE DI-(2-THIENYL)GLYCOLATE IN THE FORM OF THE QUATERNARY SALTS - ESPECIALLY SALTS OF TIOTROPIUM - PREFERRED TIOTROPIUMBROMIDE AND TIOTROPIUMBROMIDE MONOHYDRATE; REGISTERED: NL RVG26191 20011009; UK PL14598/0062 20020514
C0039France► SubscribePRODUCT NAME: TIOTROPIUM MONOHYDRATE DE BROMURE; NAT. REGISTRATION NO/DATE: NL 31393 20050708; FIRST REGISTRATION: RVG 26191 20011009
90016-1Sweden► SubscribePRODUCT NAME: OLODATEROL, INDIVIDUELLA OPTISKA ISOMERER DAERAV, BLANDNINGAR AV DE SEPARATA ENANTIOMERERNA ELLER RACEMATEN DAERAV, SYRA ADDITIONSSALTER DAERAV MED FARMAKOLOGISKT GODTAGBARA SYROR SAVAEL SOM SOLVATER OCH/ELLER HYDRATER DAERAV, SAERSKILT OLODATEROL OCH OLODATEROLHYDROKLORID; NAT. REG. NO/DATE: MT-NR 48116 20131114; FIRST REG.: MT MA 211/00401 20130918
9 5009-2014Slovakia► SubscribePRODUCT NAME: OLODATEROL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 14/0394/13-S 20131029; FIRST REGISTRATION: MT MA211/00401 20130918
00084Netherlands► SubscribePRODUCT NAME: ZOUTEN VAN TRIOTROPIUM, IN HET BIJZONDER TIOTROPIUM BROMIDE; REGISTRATION NO/DATE: RVG 26191 20011009
0140010 00101Estonia► SubscribePRODUCT NAME: OLODATEROOL;REG NO/DATE: EE 825513 03.10.2013
2014012Lithuania► SubscribePRODUCT NAME: OLODATEROLUM; REGISTRATION NO/DATE: LT/1/13/3429/001 LT/1/13/3429/003 LT/1/13/3429/003 LT/1/13/3429/004 20131031
90010-8Sweden► SubscribePRODUCT NAME: TIOTROPIUM, 3BETA-(DI(2-TIENYL)HYDROXIACETOXI)-6BETA,7BETA-EPO XI-8METYL-1ALFAH,5ALFAH-TROPANIUM, ELLER ETT SALT DAERAV; NAT. REGISRTATION NO/DATE: 18094 20020503; FIRST REGISTRATION: NL RVG 26 191 20011009
433Luxembourg► SubscribePRODUCT NAME: OLODATEROL,SES ISOMERES OPTIQUES INDIVIDUELS,MELANGES D ENANTIOMERES INDIVIDUELS OU DE RACEMATES,SES SELS D ADDITION D ACIDE AVEC DES ACIDES PHARMACEUTIQUEMENT ACCEPTABLES,AINSI QUE SES SOLVATES ET/OU SES HYDRATES,EN PARTICULIER L OLODATEROL ET LE CHLORHYDRATE D OLODATEROL
0650Netherlands► SubscribePRODUCT NAME: OLODATEROL, OPTISCHE ISOPMEREN DAARVAN, MENGSELS VAN ISOMEREN DAARVAN, ZUURADDITIEZOUTEN MET FARMACOLOGISCH AANVAARDBARE ZUREN DAARVAN, EVENALS SOLVATEN EN/OF HYDRATEN DAARVAN, IN HET BIJZONDER OLODATEROL EN OLODATEROLHYDROCHLORIDE; REGISTRATION NO/DATE: RVG 112058 20131023
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
Cerilliant
US Department of Justice
Deloitte
Boehringer Ingelheim
McKesson
Farmers Insurance
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot